Business Standard

A COMMERCIAL FEATURE

What's this ?

Commercial Feature is a Business Standard Digital Marketing Initiative.

The Editorial/Content team at Business Standard has not contributed to writing or editing these articles.

For further information, please write to assist@bsmail.in

Mobile health devices to become $41.8 bn market in 2023

While consumer devices have recently enjoyed stronger growth, clinical devices will surge after 2018 and emerge as the long-term winner, according to Lux Research

BS B2B Bureau  |  Boston, Massachusetts 

Driven by adoption of vital signs monitoring and in vitro diagnostic (IVD) devices, the mobile health (mHealth) market will grow eight-fold from $5.1 billion in 2013 to $41.8 billion in 2023, according to Lux Research.
 
Clinical mHealth devices will soar past consumer-focused counterparts after a slow start due to regulatory approval barriers and slower integration into physicians’ workflows. For instance, clinical vital signs monitoring devices will grow from $372 million in 2013 to $16 billion in 2023, a compound annual growth rate (CAGR) of 46%, while consumer applications will grow from $2.5 billion to $7 billion, an 11% CAGR.
 
“Consumer devices have seen a lot of hype but clinical devices will surpass their consumer counterparts in revenues by 2020, helped by value-added software services and generally larger revenue streams,” said Nick Kurkjy, Lux Research Associate and lead author of the report titled, ‘mHealth showdown: Consumer and clinical devices’ battle for market dominance’.
 
“Clinical markets will be able to pay much more for comparable services, especially if a device is able to reduce patient recovery times or readmission rates, which can lead to outsized cost savings for the health care provider,” he added.
 
Venture funding for mobile health devices has risen sharply since 2007, reaching $480 million in 2013, driven by the launch of the iPhone and growing popularity of the smartphone.
 
Lux Research study reveals that the considerable growth of the mobile health device market will be largely driven by the vital signs and IVD sectors. These two will combine to make a $32.9 billion market by 2023.
 
In addition, according to the study, large players from both electronics and medical device industries are starting to make acquisitions. Covidien’s purchase of Zephyr Technologies and Intel’s acquisition of Basis are among the most recent moves, as major companies look to stake their claims.

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Wed, July 02 2014. 16:23 IST
RECOMMENDED FOR YOU

Mobile health devices to become $41.8 bn market in 2023

While consumer devices have recently enjoyed stronger growth, clinical devices will surge after 2018 and emerge as the long-term winner, according to Lux Research

While consumer devices have recently enjoyed stronger growth, clinical devices will surge after 2018 and emerge as the long-term winner, according to Lux Research Driven by adoption of vital signs monitoring and in vitro diagnostic (IVD) devices, the mobile health (mHealth) market will grow eight-fold from $5.1 billion in 2013 to $41.8 billion in 2023, according to Lux Research.
 
Clinical mHealth devices will soar past consumer-focused counterparts after a slow start due to regulatory approval barriers and slower integration into physicians’ workflows. For instance, clinical vital signs monitoring devices will grow from $372 million in 2013 to $16 billion in 2023, a compound annual growth rate (CAGR) of 46%, while consumer applications will grow from $2.5 billion to $7 billion, an 11% CAGR.
 
“Consumer devices have seen a lot of hype but clinical devices will surpass their consumer counterparts in revenues by 2020, helped by value-added software services and generally larger revenue streams,” said Nick Kurkjy, Lux Research Associate and lead author of the report titled, ‘mHealth showdown: Consumer and clinical devices’ battle for market dominance’.
 
“Clinical markets will be able to pay much more for comparable services, especially if a device is able to reduce patient recovery times or readmission rates, which can lead to outsized cost savings for the health care provider,” he added.
 
Venture funding for mobile health devices has risen sharply since 2007, reaching $480 million in 2013, driven by the launch of the iPhone and growing popularity of the smartphone.
 
Lux Research study reveals that the considerable growth of the mobile health device market will be largely driven by the vital signs and IVD sectors. These two will combine to make a $32.9 billion market by 2023.
 
In addition, according to the study, large players from both electronics and medical device industries are starting to make acquisitions. Covidien’s purchase of Zephyr Technologies and Intel’s acquisition of Basis are among the most recent moves, as major companies look to stake their claims.
image
Business Standard
177 22

Mobile health devices to become $41.8 bn market in 2023

While consumer devices have recently enjoyed stronger growth, clinical devices will surge after 2018 and emerge as the long-term winner, according to Lux Research

Driven by adoption of vital signs monitoring and in vitro diagnostic (IVD) devices, the mobile health (mHealth) market will grow eight-fold from $5.1 billion in 2013 to $41.8 billion in 2023, according to Lux Research.
 
Clinical mHealth devices will soar past consumer-focused counterparts after a slow start due to regulatory approval barriers and slower integration into physicians’ workflows. For instance, clinical vital signs monitoring devices will grow from $372 million in 2013 to $16 billion in 2023, a compound annual growth rate (CAGR) of 46%, while consumer applications will grow from $2.5 billion to $7 billion, an 11% CAGR.
 
“Consumer devices have seen a lot of hype but clinical devices will surpass their consumer counterparts in revenues by 2020, helped by value-added software services and generally larger revenue streams,” said Nick Kurkjy, Lux Research Associate and lead author of the report titled, ‘mHealth showdown: Consumer and clinical devices’ battle for market dominance’.
 
“Clinical markets will be able to pay much more for comparable services, especially if a device is able to reduce patient recovery times or readmission rates, which can lead to outsized cost savings for the health care provider,” he added.
 
Venture funding for mobile health devices has risen sharply since 2007, reaching $480 million in 2013, driven by the launch of the iPhone and growing popularity of the smartphone.
 
Lux Research study reveals that the considerable growth of the mobile health device market will be largely driven by the vital signs and IVD sectors. These two will combine to make a $32.9 billion market by 2023.
 
In addition, according to the study, large players from both electronics and medical device industries are starting to make acquisitions. Covidien’s purchase of Zephyr Technologies and Intel’s acquisition of Basis are among the most recent moves, as major companies look to stake their claims.

image
Business Standard
177 22